Download the FREE ebook "Beating Myeloma: If I Knew Then What I Know Now" and arm yourself with the information about autologous stem cell transplantation, treatment options, and side effects that I wish I had known about when I began treatment.
Leukemia, lymphoma and multiple myeloma all have a robust collection of FDA approved, standard-of-care conventional therapies that your oncologist can provide. Unfortunately, these blood cancers often relapse once your blood cancer becomes resistant to conventional therapies. Further, all toxic conventional therapies cause short, long-term and late-stage collateral damage that may limit their use. Whether you are looking for a first-line therapy, integrative therapy or refractory therapy, there may come a time when you want to learn about non-conventional therapies for your blood cancer.
I was diagnosed with multiple myeloma in early 1994. I underwent several years of aggressive conventional therapies such as an autologous stem cell transplant. My oncologist told me that there was nothing more that she could do for me in September of 1997.
I have remained in complete remission from my “incurable cancer” since 1999 by living an evidence-based, non-toxic, anti-MM lifestyle through nutrition, supplementation, bone health, etc.
Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.
For more information about evidence-based, non-conventional therapies for your multiple myeloma, scroll down the page, post a question or comment and I will reply ASAP.
“Today’s myeloma therapy can help patients gain remission, but the combinations can cause their own side effects because they target normal cells as well as cancer cells. Investigators at the University of Iowa including Dr. Guido Tricot and Dr. Frank Zhan have tested mega-doses of Vitamin C in combination with the standard chemo melphalan and found that the Vitamin C can kill myeloma cells while not affecting normal cells…”
High-dose chemotherapies to treat multiple myeloma (MM) can be life-threatening due to toxicities to normal cells and there is a need to target only tumor cells and/or lower standard drug dosage without losing efficacy.
We show that pharmacologically-dosed ascorbic acid (PAA), in the presence of iron, leads to the formation of highly reactive oxygen species (ROS) resulting in cell death. PAA selectively kills CD138+MM tumor cells derived from MM and smoldering MM (SMM) but not from monoclonal gammopathy undetermined significance (MGUS) patients. PAA alone or in combination with melphalan inhibits tumor formation in MM xenograft mice. This study shows PAA efficacy on primary cancer cells and cell lines in vitro and in vivo…
“University of Iowa researchers in the Holden Comprehensive Cancer Center Multiple Myeloma Program recently found evidence that mega doses of vitamin C delivered intravenously may offer new hope to people diagnosed with multiple myeloma. The results of their study were recently published in the international journal EBioMedicine…”